ArticleNature biotechnology2024

Engineered phage with antibacterial CRISPR-Cas selectively reduce E. coli burden in mice.

Yilmaz Emre Gencay et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.